3 x
NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10:
4
residues within 4Å:
Chain A:
V.40,
N.47,
S.48,
S.49
2 PLIP interactions:
2 interactions with chain A
Hydrogen bonds:
A:N.47
Water bridges:
A:S.48
NAG.11:
2
residues within 4Å:
Chain A:
W.149,
N.243
3 PLIP interactions:
3 interactions with chain A
Hydrophobic interactions:
A:W.149
Hydrogen bonds:
A:W.149,
A:N.243
NAG.13:
3
residues within 4Å:
Chain B:
W.149,
V.241,
N.243
3 PLIP interactions:
3 interactions with chain B
Water bridges:
B:N.243,
B:N.243,
B:N.243
2 x
C8S:
(2S)-2-amino-1-[(1S,3S,5S)-3-(aminomethyl)-2-azabicyclo[3.1.0]hexan-2-yl]-2-[(1r,3R,5S,7S)-3,5-dihydroxytricyclo[3.3.1.1~3,7~]decan-1-yl]ethan-1-one(Covalent)
Berger, J.P. et al., A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice. Endocrinol Diabetes Metab (2018)